|
|
||||||||
BASIC SCIENCE INVESTIGATIONS |
Radiopharmacy Unit, Nuclear Medicine Department, LHospitalet de Llobregat, Ciutat Sanitària Universitària de Bellvitge, Barcelona, Spain
The in vitro viability, chemotaxis, and labeling stability of leukocytes labeled using 99mTc-exametazime stabilized with methylene blue were evaluated and compared with those obtained using nonstabilized 99mTc-exametazime. Methods: Two identical leukocyte populations, from 30 healthy donors, were labeled simultaneously using freshly prepared and 2-h-old stabilized 99mTc-exametazime. The following quality control techniques were performed on each labeled leukocyte sample: eosin Y staining, chemotaxis radioassay, and labeling stability at 2 h after labeling. Results: Eosin Y staining showed a cell viability of at least 98% in all samples, without a significant statistical difference between the populations. Chemotactic indices obtained with leukocytes labeled with freshly prepared, unstabilized 99mTc-exametazime were statistically greater than those obtained using 99mTc-exametazime stabilized with methylene blue (z = 2.41; P < 0.02). Labeling stability at 2 h after labeling was the same for both populations. Conclusion: The use of 99mTc-exametazime stabilized with methylene blue for leukocyte radiolabeling does not affect either cell membrane integrity or labeling stability but can cause a decrease in the cell chemotactic capacity that discourages its clinical use.
Key Words: leukocytes 99mTc-exametazime radiopharmaceutical stabilization methylene blue chemotaxis
This article has been cited by other articles:
![]() |
J. C. Hung, B. C. Iverson, K. A. Toulouse, and D. W. Mahoney Effects of Methylene Blue Stabilizer on In Vitro Viability and Chemotaxis of 99mTc-Exametazime-Labeled Leukocytes J. Nucl. Med., July 1, 2002; 43(7): 928 - 932. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |